ReviewDiabetes, obesity & metabolism2025

Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed-ratio basal insulin glucagon-like peptide-1 receptor agonist combinations?

Kevin Cowart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.